Novo Nordisk Stock Slides Before Q4 Earnings: Analysts Still See 68% Upside

Novo Nordisk A/S NVO will report its fourth-quarter earnings on Wednesday. Wall Street expects 86 cents in EPS and $11.40 billion in revenues as the company reports before market hours.The stock is down 29.55% over the past year, 4.81% YTD.Let’s look at what the charts indicate for Novo Nordisk stock and how the stock currently maps against Wall Street estimates.Read Also: Novo Nordisk Faces Investor Concerns Over Hybrid CagriSema Trial Results For Weight LossNovo Nordisk Stock Strongly Bearish Ahead of Q4 ...